PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors

Shoji Kudoh(Japan Anti Tuberculosis Association), Rintaro Noro(Xanadu Quantum Technologies (Canada))
International Journal of Oncology
November 1, 2007
10.3892/ijo.31.5.1157
Cited by 53

Related Papers

Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2005|953
Interstitial Lung Disease in Japanese Patients with Lung Cancer
|American Journal of Respiratory and Critical Care Medicine|2008|488
Serological Diagnosis of Idiopathic Pulmonary Alveolar Proteinosis
|American Journal of Respiratory and Critical Care Medicine|2000|226
Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)
|British Journal of Cancer|2005|135
E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinib
|Oncology Reports|2008|17